• 제목/요약/키워드: Coronavirus-19

검색결과 922건 처리시간 0.025초

Mediastinal Emphysema, Giant Bulla, and Pneumothorax Developed during the Course of COVID-19 Pneumonia

  • Ruihong Sun;Hongyuan Liu;Xiang Wang
    • Korean Journal of Radiology
    • /
    • 제21권5호
    • /
    • pp.541-544
    • /
    • 2020
  • The coronavirus disease 2019 (COVID-19) pneumonia is a recent outbreak in mainland China and has rapidly spread to multiple countries worldwide. Pulmonary parenchymal opacities are often observed during chest radiography. Currently, few cases have reported the complications of severe COVID-19 pneumonia. We report a case where serial follow-up chest computed tomography revealed progression of pulmonary lesions into confluent bilateral consolidation with lower lung predominance, thereby confirming COVID-19 pneumonia. Furthermore, complications such as mediastinal emphysema, giant bulla, and pneumothorax were also observed during the course of the disease.

Current Status of COVID-19 Vaccine Development: Focusing on Antigen Design and Clinical Trials on Later Stages

  • Pureum Lee;Chang-Ung Kim;Sang Hawn Seo ;Doo-Jin Kim
    • IMMUNE NETWORK
    • /
    • 제21권1호
    • /
    • pp.4.1-4.18
    • /
    • 2021
  • The global outbreak of coronavirus disease 2019 (COVID-19) is still threatening human health, economy, and social life worldwide. As a counteraction for this devastating disease, a number of vaccines are being developed with unprecedented speed combined with new technologies. As COVID-19 vaccines are being developed in the absence of a licensed human coronavirus vaccine, there remain further questions regarding the long-term efficacy and safety of the vaccines, as well as immunological mechanisms in depth. This review article discusses the current status of COVID-19 vaccine development, mainly focusing on antigen design, clinical trials in later stages, and immunological considerations for further study.

A systemic study on the vulnerability and fatality of prostate cancer patients towards COVID-19 through analysis of the TMPRSS2, CXCL10 and their co-expressed genes

  • Raza, Md. Thosif;Mizan, Shagufta
    • Genomics & Informatics
    • /
    • 제20권3호
    • /
    • pp.31.1-31.15
    • /
    • 2022
  • A pandemic of respiratory disease named coronavirus disease 2019 (COVID-19) is caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is reported prostate cancer patients are susceptible to COVID-19 infection. To understand the possible causes of prostate cancer patients' increased vulnerability and mortality from COVID-19 infection, we focused on the two most important agents, transmembrane protease serine subtype 2 (TMPRSS2) and the C-X-C motif 10 (CXCL10). When SARS-CoV-2 binds to the host cell via S protein-angiotensin-converting enzyme-2 receptor interaction, TMPRSS2 contributes in the proteolytic cleavage of the S protein, allowing the viral and cellular membranes to fuse. CXCL10 is a cytokine found in elevated level in both COVID-19 and cancer-causing cytokine storm. We discovered that TMPRSS2 and CXCL10 are overexpressed in prostate cancer and COVID-19 using the UALCAN and GEPIA2 datasets. The functional importance of TMPRSS2 and CXCL10 in prostate cancer development was then determined by analyzing the frequency of genetic changes in their amino acid sequences using the cBioPortal online portal. Finally, we used the PANTHER database to examine the pathology of the targeted genes. We observed that TMPRSS2 and CXCL10, together with their often co-expressed genes, are important in the binding activity and immune responses in prostate cancer and COVID-19 infection, respectively. Finally, we found that TMPRSS2 and CXCL10 are two putative biomarkers responsible for the increased vulnerability and fatality of prostate cancer patients to COVID-19.

COVID-19 두려움, 백신수용성과 삶의 질에 관한 연구 (A Study on COVID-19 Fear, Vaccine Acceptance, and Quality of Life)

  • 배나래
    • 한국융합학회논문지
    • /
    • 제13권1호
    • /
    • pp.253-259
    • /
    • 2022
  • 본 연구는 우리나라 국민들의 COVID-19 두려움 수준과 백신수용성을 파악하고 사람들의 삶의 만족도를 알아봄으로써 COVID-19로 활기를 잃은 사람들의 건강한 생활을 위한 구체적인 복지 대책을 마련하는데 근거를 제공하고자 한다. 연구결과는 다음과 같다. 첫째, 조사대상자가 인지하는 코로나바이러스의 두려움은 매우 높게 나타났다. 둘째, 코로나바이러스 예방 백신이 타 백신과 비교하였을 때 백신에 대한 두려움 혹은 공포감은 상당히 높았다. 셋째, 조사대상자가 지각하는 성인들의 백신수용도는 긍정적으로 나타났다. 넷째, 코로나바이러스 예방백신에 대한 정부정책의 신뢰도는 비교적 높게 나타났다. 다섯째, 삶의 질 평가에서 경제적 만족도는 다른 영역에 비해 낮았으며 정서적 만족도는 다른 영역에 비해 비교적 높은 점수로 나타났다.

소아청소년 코로나바이러스감염증-19의 치료: 치료 약제를 중심으로 (Therapeutics in the Treatment of COVID-19 for Children and Adolescents)

  • 최수한;최재홍;윤기욱
    • Pediatric Infection and Vaccine
    • /
    • 제29권1호
    • /
    • pp.1-15
    • /
    • 2022
  • 소아청소년에서 코로나바이러스감염증-19 (coronavirus disease 2019 [COVID-19])은 대부분 경증이며 특별한 치료없이 호전될 수 있다. 하지만 일부 소아청소년 COVID-19 환자에서는 중증 또는 위중증으로 진행할 수 있다. 소아청소년 COVID-19 치료 약제에 대한 임상 데이터는 제한적이지만, 중증 및 위중증 COVID-19 소아청소년 환자에서 사용 가능한 약제들은 있다. 본 종설에서는 COVID-19 치료 약제 중 항바이러스제와 면역조절제에 중점을 두고 임상 데이터와 소아청소년에 대한 권고 사항들을 논의하였다.

Nucleocapsid and Spike Proteins of SARS-CoV-2 Drive Neutrophil Extracellular Trap Formation

  • Young-Jin Youn;Yu-Bin Lee;Sun-Hwa Kim;Hee Kyung Jin;Jae-sung Bae;Chang-Won Hong
    • IMMUNE NETWORK
    • /
    • 제21권2호
    • /
    • pp.16.1-16.8
    • /
    • 2021
  • Patients with severe coronavirus disease 2019 (COVID-19) demonstrate dysregulated immune responses including exacerbated neutrophil functions. Massive neutrophil infiltrations accompanying neutrophil extracellular trap (NET) formations are also observed in patients with severe COVID-19. However, the mechanism underlying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced NET formation has not yet been elucidated. Here we show that 2 viral proteins encoded by SARS-CoV-2, the nucleocapsid protein and the whole spike protein, induce NET formation from neutrophils. NET formation was ROSindependent and was completely inhibited by the spleen tyrosine kinase inhibition. The inhibition of p38 MAPK, protein kinase C, and JNK signaling pathways also inhibited viral protein-induced NET formation. Our findings demonstrate one method by which SARSCoV-2 evades innate immunity and provide a potential target for therapeutics to treat patients with severe COVID-19.

Early CT Findings of Coronavirus Disease 2019 (COVID-19) in Asymptomatic Children: A Single-Center Experience

  • Lan Lan;Dan Xu;Chen Xia;Shaokang Wang;Minhua Yu;Haibo Xu
    • Korean Journal of Radiology
    • /
    • 제21권7호
    • /
    • pp.919-924
    • /
    • 2020
  • Objective: The current study reported a case series to illustrate the early computed tomography (CT) findings of coronavirus disease 2019 (COVID-19) in pediatric patients. Materials and Methods: All pediatric patients who were diagnosed with COVID-19 and who underwent CT scan in Zhongnan Hospital of Wuhan University from January 20, 2020 to February 28, 2020 were included in the current study. Data on clinical and CT features were collected and analyzed. Results: Four children were included in the current study. All of them were asymptomatic throughout the disease course (ranging from 7 days to 15 days), and none of them showed abnormalities in blood cell counts. Familial cluster was the main transmission pattern. Thin-section CT revealed abnormalities in three patients, and one patient did not present with any abnormal CT findings. Unilateral lung involvement was observed in two patients, and one patient showed bilateral lung involvement. In total, five small lesions were identified, including ground-glass opacity (n = 4) and consolidation (n = 1). All lesions had ill-defined margins with peripheral distribution and predilection of lower lobe. Conclusion: Small patches of ground-glass opacity with subpleural distribution and unilateral lung involvement were common findings on CT scans of pediatric patients in the early stage of the disease.

The relationship of skin disorders, COVID-19, and the therapeutic potential of ginseng: a review

  • Seoyoun Yang;Su Bin Han;Soohyun Kang;Junghyun Lee;Dongseon Kim;Anastasiia Kozlova;Minkyung Song;See-Hyoung Park;Jongsung Lee
    • Journal of Ginseng Research
    • /
    • 제47권1호
    • /
    • pp.33-43
    • /
    • 2023
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made significant impacts on global public health, including the development of several skin diseases that have arisen primarily as a result of the pandemic. Owing to the widespread expansion of coronavirus disease 19 (COVID-19), the development of effective treatments for these skin diseases is drawing attention as an important social issue. For many centuries, ginseng and its major active ingredients, ginsenosides and saponins, have been widely regarded as herbal medicines. Further, the anti-viral action of ginseng suggests its potential effectiveness as a therapeutic agent against COVID-19. Thus, the aim of this review was to examine the association of skin lesions with COVID-19 and the effect of ginseng as a therapeutic agent to treat skin diseases induced by COVID-19 infection. We classified COVID-19-related skin disorders into three categories: caused by inflammatory, immune, and complex (both inflammatory and immune) responses and evaluated the evidence for ginseng as a treatment for each category. This review offers comprehensive evidence on the improvement of skin disorders induced by SARS-CoV-2 infection using ginseng and its active constituents.

코로나19의 증거생성 질병관리 (Evidence-Developing Disease Control of Coronavirus Disease 2019)

  • 박은철
    • 보건행정학회지
    • /
    • 제30권4호
    • /
    • pp.431-432
    • /
    • 2020
  • Coronavirus disease 2019 (COVID-19) has been going on for nearly a year. As of December 1, 2020, more than 60 million confirmed cases and 1.4 million deaths have occurred in 220 countries and territories. There is no effective treatment for COVID-19 so far, and vaccines are being developed. However, the vaccine of COVID-19 can be freed from COVID-19 only if there are positive answers to some questions: "Aren't there any major side effects from the vaccine?"; "Is the vaccine effective for enough time?"; "Does the vaccine sufficiently reduce the mortality rate?"; and "Does the vaccine sufficiently reduce the reproduction number?" The fight against COVID-19 will continue for a long time. Therefore, we need to respond by developing the evidence for control of COVID-19, the emerging infectious disease. Extensive quarantine measures in the early stages of COVID-19 need to be elaborated through developing the evidence. Korea Disease Control and Prevention Agency should establish a database for evidence developing COVID-19 control. In this database, based on more than 3 million tested individuals, epidemiological investigation results, health insurance claims data, and government data such as the Ministry of Public Administration and Security, etc. should be linked. It is necessary to disclose this database to academia, etc. to create the evidences of COVID-19 and manage COVID-19 through these. And through the developed evidences, guidelines for physical health and mental health in the era of Corona 19 should be developed.

Lightweight Convolutional Neural Network (CNN) based COVID-19 Detection using X-ray Images

  • Khan, Muneeb A.;Park, Hemin
    • Journal of Multimedia Information System
    • /
    • 제8권4호
    • /
    • pp.251-258
    • /
    • 2021
  • In 2019, a novel coronavirus (COVID-19) outbreak started in China and spread all over the world. The countries went into lockdown and closed their borders to minimize the spread of the virus. Shortage of testing kits and trained clinicians, motivate researchers and computer scientists to look for ways to automatically diagnose the COVID-19 patient using X-ray and ease the burden on the healthcare system. In recent years, multiple frameworks are presented but most of them are trained on a very small dataset which makes clinicians adamant to use it. In this paper, we have presented a lightweight deep learning base automatic COVID-19 detection system. We trained our model on more than 22,000 dataset X-ray samples. The proposed model achieved an overall accuracy of 96.88% with a sensitivity of 91.55%.